Zai Lab

IPO

Public · Shanghai, China · Founded 2014 · $130.0M raised

Headquarters
Shanghai
Employees
1001–5000
Founded
2014
Business Model
B2B
Total Funding
$130.0M
Last Round
$100.0M Series BJun 2016
Rounds
2
Type
Public

About

Zai Lab is a patient-focused, commercial-stage global biopharmaceutical company based in China and the United States. Founded in 2014 by Dr. Samantha Du, it discovers, develops, and commercializes best-in-class and first-in-class therapies for oncology, immunology, neuroscience, and infectious disease. The company combines scientific innovation with operational scale across headquarters in Cambridge, Massachusetts, and Shanghai, plus teams in Greater China, the U.S., and Europe. Its pipeline includes zocilurtatug pelitecan, a DLL3-targeted antibody-drug conjugate in clinical trials for small cell lung cancer, along with other global programs such as ZL-1503 for atopic dermatitis and ZL-6201 for solid tumors.

Summary

Zai Lab is a Biotech company based in Shanghai, China, founded in 2014. It has raised $130.0M in total across 2 rounds, most recently a $100.0M Series B round in Jun 2016.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPONov 2017

Sign up to see all 3 rounds

Series A through IPO — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Zai Lab on Indexed.vc
<a href="https://indexed.vc/companies/zai-lab"><img src="https://indexed.vc/api/badge/company/zai-lab" alt="Zai Lab on Indexed.vc" width="260" height="76" /></a>